Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China flag China · Delayed Price · Currency is CNY
16.82
+0.77 (4.80%)
May 12, 2026, 3:00 PM CST

Cabio Biotech (Wuhan) Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,7673,8833,2033,0135,4387,373
Market Cap Growth
-25.98%21.24%6.31%-44.60%-26.24%55.15%
Enterprise Value
2,5953,7413,0772,7604,9106,676
Last Close Price
16.8223.2818.8817.4931.3042.04
PE Ratio
51.0327.0225.7932.9784.4857.34
Forward PE
-19.0422.8923.21--
PS Ratio
6.626.905.776.7912.5521.00
PB Ratio
1.732.362.042.023.825.34
P/TBV Ratio
1.792.442.122.103.935.39
P/FCF Ratio
28.4930.93----
P/OCF Ratio
12.3314.3818.5143.7330.8371.38
PEG Ratio
-0.750.750.75--
EV/Sales Ratio
6.206.645.546.2211.3319.02
EV/EBITDA Ratio
25.2117.4119.5722.4254.3153.40
EV/EBIT Ratio
63.0224.4029.8936.2876.2965.65
EV/FCF Ratio
26.7129.80----
Debt / Equity Ratio
0.130.050.010.010.020.00
Debt / EBITDA Ratio
1.630.390.120.100.360.02
Debt / FCF Ratio
2.130.66----
Net Debt / Equity Ratio
-0.11-0.12-0.08-0.15-0.35-0.49
Net Debt / EBITDA Ratio
-1.43-0.91-0.85-1.84-5.47-5.39
Net Debt / FCF Ratio
-1.85-1.553.470.996.769.60
Asset Turnover
0.230.320.340.280.280.25
Inventory Turnover
1.351.882.602.733.292.46
Quick Ratio
2.573.074.674.774.3514.93
Current Ratio
3.764.446.456.315.0316.59
Return on Equity (ROE)
3.11%8.67%7.84%5.92%4.39%9.71%
Return on Assets (ROA)
2.15%5.40%3.90%2.95%2.63%4.49%
Return on Invested Capital (ROIC)
3.33%9.13%6.55%5.98%6.19%14.97%
Return on Capital Employed (ROCE)
3.70%9.00%6.50%5.10%4.50%7.30%
Earnings Yield
1.99%3.70%3.88%3.03%1.18%1.74%
FCF Yield
3.51%3.23%-1.20%-7.59%-1.34%-0.95%
Dividend Yield
1.25%-1.06%1.14%0.69%0.56%
Payout Ratio
66.24%24.95%27.38%40.04%61.90%31.01%
Buyback Yield / Dilution
-0.75%0.44%0.80%0.11%-0.69%-0.31%
Total Shareholder Return
0.50%0.44%1.87%1.26%-0.01%0.26%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.